These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35990674)

  • 1. Interferon α-2b spray shortened viral shedding time of SARS-CoV-2 Omicron variant: An open prospective cohort study.
    Xu N; Pan J; Sun L; Zhou C; Huang S; Chen M; Zhang J; Zhu T; Li J; Zhang H; Gao Y
    Front Immunol; 2022; 13():967716. PubMed ID: 35990674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-α2b spray inhalation did not shorten virus shedding time of SARS-CoV-2 in hospitalized patients: a preliminary matched case-control study.
    Hao SR; Yan R; Zhang SY; Lian JS; Cai H; Zhang XL; Zheng L; Jia HY; Hu JH; Yu GD; Gu JQ; Ye CY; Jin CL; Lu YF; Xin JJ; Sheng JF; Yang YD
    J Zhejiang Univ Sci B; 2020 Aug.; 21(8):628-636. PubMed ID: 32748578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open, prospective cohort study of VV116 in Chinese participants infected with SARS-CoV-2 omicron variants.
    Shen Y; Ai J; Lin N; Zhang H; Li Y; Wang H; Wang S; Wang Z; Li T; Sun F; Fan Z; Li L; Lu Y; Meng X; Xiao H; Hu H; Ling Y; Li F; Li H; Xi C; Gu L; Zhang W; Fan X
    Emerg Microbes Infect; 2022 Dec; 11(1):1518-1523. PubMed ID: 35579892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbidities prolonged viral shedding of patients infected with SARS-CoV-2 omicron variant in Shanghai: A multi-center, retrospective, observational study.
    Pei L; Chen Y; Zheng X; Gong F; Liu W; Lin J; Zheng R; Yang Z; Bi Y; Chen E
    J Infect Public Health; 2023 Feb; 16(2):182-189. PubMed ID: 36566602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID-19: A retrospective study in two designated hospitals in Anhui, China.
    Zuo Y; Liu Y; Zhong Q; Zhang K; Xu Y; Wang Z
    J Med Virol; 2020 Nov; 92(11):2666-2674. PubMed ID: 32492211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study.
    He XL; Zhou YY; Fu W; Xue YE; Liang MY; Yang BH; Ma WL; Zhou Q; Chen L; Zhang JC; Wang XR
    Curr Med Sci; 2021 Dec; 41(6):1096-1104. PubMed ID: 34515914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative therapeutic efficacy of interferon alfa-2b and combination lopinavir/ritonavir plus interferon alfa-2b against SARS-CoV-2.
    Liu J; Du C; Pu L; Xiang P; Xiong H; Xie W; Chen Z; Li A
    BMC Infect Dis; 2021 Aug; 21(1):885. PubMed ID: 34461841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of secondary attack rate and viable virus shedding between patients with SARS-CoV-2 Delta and Omicron variants: A prospective cohort study.
    Kang SW; Kim JY; Park H; Lim SY; Kim J; Chang E; Bae S; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Park MS; Kim SH
    J Med Virol; 2023 Jan; 95(1):e28369. PubMed ID: 36458559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between immunity and viral shedding duration in non-severe SARS-CoV-2 Omicron variant-infected patients.
    He S; Fang Y; Yang J; Wang W
    Front Public Health; 2022; 10():1032957. PubMed ID: 36620263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of culture-competent virus shedding duration of SARS-CoV-2 Omicron variant in regard to vaccination status: A prospective cohort study.
    Kang SW; Park H; Yeun Kim J; Bae JY; Park MS; Kim SH
    Vaccine; 2023 Apr; 41(17):2769-2772. PubMed ID: 37003909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and risk factors analysis of viral shedding time in mildly symptomatic and asymptomatic patients with SARS-CoV-2 Omicron variant infection in Shanghai.
    Li R; Jin C; Zhang L; Kong D; Hu K; Xuan M; Liu Q; Li S; Zhang K; Xue Y
    Front Public Health; 2022; 10():1073387. PubMed ID: 36684919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivated COVID-19 vaccine booster dose shortened the viral shedding time of patients infected with the Omicron variant BA.2.
    Wu J; Shi X; Tao B; Zhan Y; Lu X; Wang J
    Int J Infect Dis; 2023 Jun; 131():26-31. PubMed ID: 36948448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical predictors and RT-PCR profile of prolonged viral shedding in patients with SARS-CoV-2 Omicron variant in Shanghai: A retrospective observational study.
    Zhang W; Zhou S; Wang G; Cao M; Sun D; Lu W; Shi L; Guo Y; Xu X; Pu Y; Chen C; Yang H; Sun Y; Hu H; Fang B
    Front Public Health; 2022; 10():1015811. PubMed ID: 36353283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with prolonged viral shedding in older patients infected with Omicron BA.2.2.
    Zhong W; Yang X; Jiang X; Duan Z; Wang W; Sun Z; Chen W; Zhang W; Xu J; Cheng J; Yuan X; Li Y
    Front Public Health; 2022; 10():1087800. PubMed ID: 36711364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Coronavirus Disease 2019 Patients With Prolonged Postsymptomatic Viral Shedding With Leflunomide: A Single-center Randomized Controlled Clinical Trial.
    Wang M; Zhao Y; Hu W; Zhao D; Zhang Y; Wang T; Zheng Z; Li X; Zeng S; Liu Z; Lu L; Wan Z; Hu K
    Clin Infect Dis; 2021 Dec; 73(11):e4012-e4019. PubMed ID: 32955081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of pediatric cases infected with the SARS-CoV-2 Omicron variant in a tertiary children's medical center in Shanghai, China.
    Shen N; Wu YF; Chen YW; Fang XY; Zhou M; Wang WY; Tang MY; Pan QH; Ma J; Zhang H; Cao Q
    World J Pediatr; 2023 Jan; 19(1):87-95. PubMed ID: 36251118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to Moderate COVID-19: A Phase 2 Randomized Clinical Trial.
    Cairns DM; Dulko D; Griffiths JK; Golan Y; Cohen T; Trinquart L; Price LL; Beaulac KR; Selker HP
    JAMA Netw Open; 2022 Feb; 5(2):e2144942. PubMed ID: 35138402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of Reyanning mixture in patients infected with SARS-CoV-2 Omicron variant: A prospective, open-label, randomized controlled trial.
    Xu X; Zhou S; Chen C; Li J; Wu H; Jin G; Zhou J; Wang G; Cao M; Sun D; Zhang W; Peng W; Pu Y; Sun Y; Fang B; Xu J
    Phytomedicine; 2023 Jan; 108():154514. PubMed ID: 36334390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [
    Loginova SY; Shсhukina VN; Savenko SV; Borisevich SV
    Vopr Virusol; 2021 May; 66(2):123-128. PubMed ID: 33993682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with prolonged viral shedding of SARS-CoV-2 Omicron variant infection in Shanghai: A multicenter, retrospective, observational study.
    Liu W; Gong F; Zheng X; Pei L; Wang X; Yang S; Zhao S; Yang Z; Lin J; Jing F; Shang H; Bi Y; Wei D; Chen E; Chen Y
    J Med Virol; 2023 Dec; 95(12):e29342. PubMed ID: 38130170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.